Press Release Distribution
 

Members Login  |  Register  |  Why Join?   Follow us on Google+Follow us on TwitterFind us on LinkedInFind Us on FacebookSubscribe to our RSS FeedsSubscribe to our YouTube ChannelFind us on RebelMouse

Video Releases    |    Pricing & Distribution Plans    |    Today's News    |    News By Category    |    News By Date    |    Business Directory
All Press Releases for February 15, 2014 »
RSS Feeds RSS Feed     Print this news Printer Friendly     Email this news Email It    Create PDF PDF Version   



The Larvol Group to Demonstrate a Free Tool for Identifying KOLs and Investigators at Pharma CI Europe

The Larvol Group, LLC announced today that it will demonstrate its new KOL and Investigator tracker debuting on Larvol Sigma, a free online pharmaceutical intelligence platform, at the Pharma CI Europe conference in Barcelona on February 17th.
 
x-small text small text medium text large text

    SAN DIEGO, CA, February 15, 2014 /24-7PressRelease/ -- Larvol Sigma is the first free clinical trial and pipeline intelligence platform. In addition to faster, easier access to ClinicalTrials.gov and EudraCT, the platform provides advanced analytics tailored to meet the specific needs of the pharmaceutical and biotech industries. With a database containing over 5,000 drugs as well as more than 150,000 individual drug trials across all major indications, Larvol Sigma is a comprehensive free resource for researchers and industry professionals.

"From trial registries and publications to financial disclosure reports, large amounts of data about KOLs falls within the public domain," said company President, Bruno Larvol "but there are substantial challenges in extracting and organizing the data in a meaningful way. We have brought together data mining and relationship visualization tools to allow users to easily identify and prioritize KOLs according to their work with more than 4,000 indications, products and companies." To preview Larvol Sigma, please visit http://www.larvolsigma.com.

For more information regarding how The Larvol Group can assist your organization, please visit our booth at the conference. If you would like to schedule a meeting with Bruno Larvol or Vice-president Laura Farmer during the event, please contact Natalie Gulley at natalie.gulley@larvol.com or (415) 874-3310.

About The Larvol Group, LLC: Founded in 2004, The Larvol Group (www.larvol.com) is a San Francisco-based competitive intelligence company which provides innovative business intelligence services for the pharmaceutical industry. Their customized Market Intelligence Reports track relevant news, clinical trials and developments in the competitive landscape of a given indication. Drawing on the knowledge of over 100 professionals, The Larvol Group has expertise in all major therapeutic areas, including oncology, cardiovascular, metabolic diseases, CNS, immunology, women's health and pain management. Their diverse portfolio of clients includes top pharmaceutical companies and small to midsized biotech firms.



---
Press release service and press release distribution provided by http://www.24-7pressrelease.com


# # #

Read more Press Releases from Natalie Gulley:

Contact Information:
Natalie Gulley
The Larvol Group

San Francisco, California
United States
Voice: 415.874.3310
E-Mail: Email us Here
Website: Visit Our Website
Disclaimer:
If you have any questions regarding information in this press release, please contact the person listed in the contact module of this page. Please do not attempt to contact 24-7PressRelease. We are unable to assist you with any information regarding this release. 24-7PressRelease disclaims any content contained in this press release. Please see our complete Terms of Service disclaimer for more information.